Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
4
×
Tags
boston blog main
boston top stories
life sciences
national blog main
4
×
national top stories
biotech
boston
clinical trials
new york blog main
startups
atlas venture
cancer
deals
gene therapy
san diego blog main
san francisco blog main
accelerator
adeno-associated virus
airbnb
allosteric
amazon web services (aws)
artificial intelligence (a.i.)
astellas pharma
athelas
atomwise
atopic dermatitis
audentes therapeutics
autoimmune disorders
avidity biosciences
benchling
biotechnology
bluebird bio
brace pharma
chemotherapy
cisplatin
cleva pharma
coinbase
coworking
cruise
culture biosciences
What
ago
4
×
medicines
therapeutics
years
biotechs
adding
address
adds
admits
aiming
allosteric
balance
big
build
classes
clinic
combinator
companies
considering
data
decibel
disease
diseases
drug
drugs
dug
dyne
early
elusive
emerged
expected
experimental
eyes
focus
forms
genetic
having
hearing
hotspot
humans
Language
unset
4
×
Current search:
ago
×
" national blog main "
×
unset
×
photo
×
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@xconomy.com
4 years ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com
4 years ago
Decibel Therapeutics Strikes a Balance, Adding Regenerative Med Focus
@xconomy.com
4 years ago
Five Years After Y Combinator First Admits Biotechs, They’re Dug In